THE HYDRATION PHARMACEUTICALS COMPANY LIMITED (HPC)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for HPC during the last 90 days, indicating Moderate trading activity

Latest HPC Signals
22/04/2026	SELL
HPC Share Price
Current Price	$0.004
52 Week High	$0.016
52 Week Low:	$0.003
Trading at (% of 52 Week High)	25.00%

Business Overview

The Hydration Pharmaceuticals Company Limited (ASX: HPC) is an Australian company that develops and commercializes pharmaceutical products focused on hydration and electrolyte balance. Their products aim to support medical treatments and improve patient health outcomes related to dehydration.

ASX Sector Overview

Sector:   Household & Personal Products

The Household & Personal Products sector on the ASX includes companies that manufacture and sell items used for daily personal care and household cleaning. This sector covers products such as toiletries, cosmetics, skincare, cleaning agents, and hygiene supplies. Companies in this sector often invest in research and development to create innovative and safe products that meet consumer needs. The sector is influenced by consumer trends, regulatory standards, and shifts towards sustainability and natural ingredients. It plays a key role in everyday life by providing essential goods for personal and home use.

Latest AI Recommendation

The SELL recommendation for HPC is supported by the extremely low current price indicating potential distress or lack of market confidence. The pharmaceutical sector's volatility and possible liquidity concerns further justify caution. However, without detailed fundamental or technical data, the confidence remains high but not very high.

Latest  THE HYDRATION PHARMACEUTICALS COMPANY LIMITED(HPC)   News